OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-GRIN2D antibodies

Anti-GRIN2D Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA323554 Anti-GRIN2D Rabbit Polyclonal Antibody 100ul $325 2-3 Weeks
Add to Shopping Cart

spacer
IHC(2)

OriGene Data

ImmunogenSynthetic peptide corresponding to a region derived from 1264-1278 amino acids of Human glutamate receptor, ionotropic, N-methyl D-aspartate 2D
Clone Name IsotypeIgG
Species ReactivityHuman, Mouse, Rat Concentration0.5mg/ml
Guaranteed Application *IHC Suggested DilutionsELISA: 1:1000-2000, IHC: 1:10-50
BufferPBS pH7.3, 0.05% NaN3, 50% glycerol
Purification Antigen affinity purification

Reference Data

Target NameHomo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2D (GRIN2D)
Alternative NameEB11; GluN2D; NMDAR2D; NR2D
Database LinkNP_000827
Entrez Gene 2906 Human
Entrez Gene 14814 Mouse
Entrez Gene 24412 Rat
FunctionN-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved in long-term potentiation; an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: NMDAR2A (GRIN2A); NMDAR2B (GRIN2B); NMDAR2C (GRIN2C); and NMDAR2D (GRIN2D).
Related PathwayTransmembraneIon Channels: Glutamate ReceptorsDruggable Genome Calcium signaling pathwayNeuroactive ligand-receptor interactionLong-term potentiationAlzheimer's diseaseAmyotrophic lateral sclerosis (ALS)

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Predicted cell location: Cytoplasm. Positive control: Human breast and ovarian cancer tissue. Recommended dilution: 1/10-50 The image on the left is immunohistochemistry of paraffin-embedded Human breast and ovarian cancer tissue using GRIN2D antibody at dilution 1/10, on the right is treated with the synthetic peptide. (Original magnification:x200)
spacer
Predicted cell location: Cytoplasm. Positive control: Human breast and ovarian cancer tissue. Recommended dilution: 1/10-50 The image on the left is immunohistochemistry of paraffin-embedded Human breast and ovarian cancer tissue using GRIN2D antibody at dilution 1/10, on the right is treated with the synthetic peptide. (Original magnification:x200)
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title